- Home
- EMKR vs OMGA Comparison
EMKR vs OMGA Comparison
Compare EMKR & OMGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMKR
- OMGA
- Stock Information
- Founded
- EMKR 1984
- OMGA 2017
- Country
- EMKR United States
- OMGA United States
- Employees
- EMKR N/A
- OMGA N/A
- Industry
- EMKR Semiconductors
- OMGA Biotechnology: Pharmaceutical Preparations
- Sector
- EMKR Technology
- OMGA Health Care
- Exchange
- EMKR Nasdaq
- OMGA Nasdaq
- Market Cap
- EMKR 27.1M
- OMGA 27.1M
- IPO Year
- EMKR 1997
- OMGA 2021
- Fundamental
- Price
- EMKR $3.07
- OMGA $0.16
- Analyst Decision
- EMKR Buy
- OMGA Strong Buy
- Analyst Count
- EMKR 2
- OMGA 5
- Target Price
- EMKR $3.00
- OMGA $9.20
- AVG Volume (30 Days)
- EMKR 142.4K
- OMGA 26.1M
- Earning Date
- EMKR 02-13-2025
- OMGA 03-27-2025
- Dividend Yield
- EMKR N/A
- OMGA N/A
- EPS Growth
- EMKR N/A
- OMGA N/A
- EPS
- EMKR N/A
- OMGA N/A
- Revenue
- EMKR $81,078,000.00
- OMGA $8,095,000.00
- Revenue This Year
- EMKR $12.69
- OMGA $181.38
- Revenue Next Year
- EMKR N/A
- OMGA N/A
- P/E Ratio
- EMKR N/A
- OMGA N/A
- Revenue Growth
- EMKR N/A
- OMGA 185.04
- 52 Week Low
- EMKR $0.78
- OMGA $0.10
- 52 Week High
- EMKR $4.60
- OMGA $4.46
- Technical
- Relative Strength Index (RSI)
- EMKR 55.77
- OMGA 31.40
- Support Level
- EMKR $3.05
- OMGA $0.15
- Resistance Level
- EMKR $3.15
- OMGA $0.25
- Average True Range (ATR)
- EMKR 0.05
- OMGA 0.08
- MACD
- EMKR -0.00
- OMGA 0.01
- Stochastic Oscillator
- EMKR 37.50
- OMGA 16.02
About EMKR EMCORE Corporation
EMCORE Corp is a provider of sensors and navigation systems for the aerospace and defense market. The company operates in one reporting segment, Inertial Navigation, whose product technology categories include: (a) FOG, (b) QMEMS, (c) RLG, in each case which serve the aerospace and defense market. The company operates geographically in United States and Canada, which is the key revenue generator; Asia; Europe; and Other.
About OMGA Omega Therapeutics Inc.
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.